Skip to main content Help with accessibility Skip to main navigation

CARIPRAZINE hard capsules (Reagila®▼) for the treatment of schizophrenia in adult patients

CCG Approval Status:

Date Added: 13 - Jul - 2021
Body System:
Amber retained

The Pan Mersey Area Prescribing Committee recommends the prescribing of CARIPRAZINE hard capsules (Reagila®▼), following specialist initiation, as a non-first line treatment option for adult patients with predominant negative symptoms of schizophrenia.